Predictions
Aphria Inc.
Start price
Target price
Perf. (%)
€4.70
05.11.20
05.11.20
-
05.11.21
05.11.21
170.32%
06.11.21
06.11.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Edesa Biotech Inc
Start price
Target price
Perf. (%)
€6.15
21.09.20
21.09.20
€4.00
04.11.21
04.11.21
17.07%
05.11.21
05.11.21
Probably not worthwhile Investment
High valuation
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.08
20.05.20
20.05.20
€4.50
04.11.21
04.11.21
56.99%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Burcon Nutrascience Corp.
Start price
Target price
Perf. (%)
€1.01
28.04.20
28.04.20
€1.00
04.11.21
04.11.21
35.05%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€13.53
30.03.20
30.03.20
€29.00
04.11.21
04.11.21
72.28%
05.11.21
05.11.21
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€7.15
26.03.20
26.03.20
-
04.11.21
04.11.21
10.29%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
BELLUS Health Inc.
Start price
Target price
Perf. (%)
€2.80
04.01.20
04.01.20
-
04.11.21
04.11.21
112.50%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€18.00
21.12.19
21.12.19
€30.00
04.11.21
04.11.21
-36.06%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Aphria Inc.
Start price
Target price
Perf. (%)
€4.29
25.11.19
25.11.19
-
04.11.21
04.11.21
196.12%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.85
08.02.19
08.02.19
€21.00
04.11.21
04.11.21
372.71%
05.11.21
05.11.21
BELLUS Health Inc.
Start price
Target price
Perf. (%)
€4.89
15.09.21
15.09.21
€5.85
15.09.22
15.09.22
1.27%
22.10.21
22.10.21
Could be very worthwhile Investment >20% year
Future proof or reliable business model
Higher risks for its business
THC Biomed International Inc.
Start price
Target price
Perf. (%)
€0.070
17.04.20
17.04.20
-
04.11.21
04.11.21
-21.43%
14.10.21
14.10.21
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€19.92
28.09.21
28.09.21
-
28.09.22
28.09.22
-6.85%
02.10.21
02.10.21
Could be worthwhile Investment >10% per year
Edesa Biotech Inc
Start price
Target price
Perf. (%)
€8.53
20.09.21
20.09.21
-
20.09.22
20.09.22
-27.86%
02.10.21
02.10.21
Could be worthwhile Investment >10% per year
Capable Management
Little innovation
ESSA Pharma Inc
Start price
Target price
Perf. (%)
€6.85
16.08.21
16.08.21
-
16.08.22
16.08.22
-0.73%
22.08.21
22.08.21
Risky Investment
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.95
05.08.21
05.08.21
-
05.08.22
05.08.22
23.44%
08.08.21
08.08.21
Could be worthwhile Investment >10% per year
Trillium Therapeutics
Start price
Target price
Perf. (%)
€8.28
07.09.20
07.09.20
-
04.11.21
04.11.21
-21.91%
15.07.21
15.07.21
Could be very worthwhile Investment >20% year
Aptose Biosciences
Start price
Target price
Perf. (%)
€4.64
01.05.21
01.05.21
€4.50
01.05.22
01.05.22
-30.60%
11.06.21
11.06.21
Could be worthwhile Investment >10% per year
LexaGene Holdings Inc.
Start price
Target price
Perf. (%)
€0.92
11.02.21
11.02.21
€2.00
11.02.22
11.02.22
-52.92%
20.04.21
20.04.21
Aphria Inc.
Start price
Target price
Perf. (%)
€9.43
14.01.21
14.01.21
€28.00
72.92%
12.03.21
12.03.21
Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
Aphria Inc.
Start price
Target price
Perf. (%)
€13.38
08.03.21
08.03.21
€15.00
13.62%
10.03.21
10.03.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€20.95
10.02.21
10.02.21
€22.00
11.75%
11.02.21
11.02.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Burcon Nutrascience Corp.
Start price
Target price
Perf. (%)
€2.81
10.01.21
10.01.21
-
10.01.22
10.01.22
7.84%
23.01.21
23.01.21
Risky Investment
Aphria Inc.
Start price
Target price
Perf. (%)
€7.48
11.01.21
11.01.21
-
11.01.22
11.01.22
39.14%
15.01.21
15.01.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€5.20
07.11.20
07.11.20
€6.40
23.49%
30.11.20
30.11.20
Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Revenue growth >5% per year expected